title: Cisplatin plus etoposide in advanced non-small cell lung cancer patients age of 70 years or older.
authors.forename: Ozkan
authors.initials: O
authors.lastname: Kanat
authors.forename: Turkkan
authors.initials: T
authors.lastname: Evrensel
authors.forename: Mutlu
authors.initials: M
authors.lastname: Demiray
authors.forename: Ender
authors.initials: E
authors.lastname: Kurt
authors.forename: Guzin
authors.initials: G
authors.lastname: Gonullu
authors.forename: Murat
authors.initials: M
authors.lastname: Arslan
authors.forename: Osman
authors.initials: O
authors.lastname: Manavoglu
authors.forename: Atilla
authors.initials: A
authors.lastname: Ozkan
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000556:secondary; D002945:Cisplatin / Q000008:administration & dosage* / Q000009:adverse effects; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage* / Q000009:adverse effects; D005240:Feasibility Studies; D005260:Female; D006299:Health Services for the Aged; D006801:Humans; D007262:Infusions, Intravenous; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D016896:Treatment Outcome
chemical_list: D005047:Etoposide; D002945:Cisplatin